PureTech Health PLC

PureTech Health PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)224.50
  • Today's Change-0.50 / -0.22%
  • Shares traded125.81k
  • 1 Year change+24.72%
  • Beta0.9488
Data delayed at least 20 minutes, as of May 26 2023 17:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, PureTech Health PLC (PRTC:LSE) closed at 224.50, -25.17% below its 52-week high of 300.00, set on Dec 09, 2022.
52-week range
145.80Jun 17 2022300.00Dec 09 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close225.00
Average volume168.43k
Shares outstanding277.75m
Free float235.40m
P/E (TTM)--
Market cap622.44m GBP
EPS (TTM)-0.1418
Data delayed at least 20 minutes, as of May 26 2023 17:18 BST.
More ▼

Investors Chronicle View

The last IC recommendation on PureTech Health PLC shares was Buy at 207.00 on 28 Apr 2023Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.